{"ticker": {"uuid": "086ee816-c150-4932-a1b7-61fdc8793cde", "symbol": "OPK", "name": "Opko Health Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "OPK5733212 Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the OPK5733212 bond issued by OPKO Health, Inc. The bond has a 3.75% coupon rate, was issued on January 9, 2024, and matures on January 15, 2029, with a face value of $1,000. OPKO Health, Inc. is described as a biopharmaceutical and diagnosti", "url": "https://www.tradingview.com/symbols/FINRA-OPK5733212/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-15T02:11:29", "published_display": "15 Jul 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zacks Research Has Weak Estimate for OPKO Health Q2 Earnings", "summary": "Zacks Research has reduced its Q2 2028 EPS estimate for OPKO Health (NASDAQ:OPK) to -$0.05 from -$0.04, reflecting a weaker outlook, though the full-year estimate remains at -$0.29 per share. This follows the company's recent quarterly results where EPS matched expectations at -$", "url": "https://www.marketbeat.com/instant-alerts/zacks-research-has-weak-estimate-for-opko-health-q2-earnings-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T05:39:46", "published_display": "13 Jul 2026 05:39", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in OPKO Health, Inc. Stocks", "summary": "This article lists various ETFs that invest in OPKO Health, Inc. stocks. It provides a detailed table including each ETF's market value, weight of OPKO in its holdings, issuer, management style, expense ratio, AUM, price, and 3-year NAV total return. The ETFs cover different inve", "url": "https://www.tradingview.com/symbols/LSE-0KCS/etfs/", "source_name": "TradingView", "published_at": "2026-07-10T20:10:34", "published_display": "10 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Piper Sandler 36th Annual Healthcare Conference Summary", "summary": "OPKO Health presented at the Piper Sandler 36th Annual Healthcare Conference, highlighting the growth of its Ngenla human growth hormone, with Pfizer projecting $500 million to $1 billion in near-term sales. The company also discussed its ModeX platform for multispecific antibodi", "url": "https://quartr.com/events/opko-health-opk-piper-sandler-36th-annual-healthcare-conference_3YClMjJo", "source_name": "Quartr", "published_at": "2026-07-05T20:10:34", "published_display": "05 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPK - Opko Health Inc Options", "summary": "This article provides a comprehensive overview of Opko Health Inc. (OPK) stock, including its latest closing price, key financial metrics, performance indicators, and ownership details. It details statistics such as market capitalization, income, sales, P/E ratio, EPS, insider an", "url": "https://finviz.com/stock?t=OPK&ta=1&p=d&ty=oc&b=2", "source_name": "Finviz", "published_at": "2026-07-03T17:40:13", "published_display": "03 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Inc focuses on diagnostics and pharmaceuticals as investors weigh long-term prospects", "summary": "OPKO Health Inc is building its business around both diagnostic services and specialty pharmaceutical products. The company aims to diversify its revenue streams and capitalize on growth opportunities in the healthcare sector. Investors are closely monitoring OPKO's strategy for ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/opko-health-inc-focuses-on-diagnostics-and-pharmaceuticals-as-investors/69680853", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T15:10:12", "published_display": "03 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 13D/A OPKO HEALTH For: 1 July By Investing.com", "summary": "This article announces that OPKO Health has filed a Form 13D/A for July 1st. It also includes general market data, popular news, and various financial statistics. The content itself provides no further details beyond the filing announcement.", "url": "https://uk.investing.com/news/stock-market-news/form-13da-opko-health-for-1-july-93CH-4753592", "source_name": "Investing.com UK", "published_at": "2026-07-03T07:10:12", "published_display": "03 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Ownership Update Draws Attention, Is The 55% Undervalued View Convincing?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phillip Frost (NASDAQ: OPK) reports 34.1% beneficial stake in OPKO", "summary": "Phillip Frost has reported a significant 34.1% beneficial stake in OPKO Health (NASDAQ: OPK), totaling 255,429,406 shares. This ownership includes holdings through Gamma Trust, Frost Nevada Investments Trust, a philanthropic foundation, stock options, and restricted stock units. ", "url": "https://www.stocktitan.net/sec-filings/OPK/schedule-13d-a-opko-health-inc-amended-major-shareholder-report-62b64767f9ab.html", "source_name": "Stock Titan", "published_at": "2026-07-01T19:39:40", "published_display": "01 Jul 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Opko Health, Inc. \u2013 NASDAQ:OPK", "summary": "This article presents financial data for Opko Health, Inc. (NASDAQ: OPK), specifically focusing on its enterprise value to EBITDA forward metric. The content was sourced from TradingView and includes general company and market information, but the specific financial value for the", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T06:10:45", "published_display": "29 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. Actuals & Estimates (BMV:OPK)", "summary": "This article provides an overview of OPKO Health, Inc. (BMV:OPK) stock, including current price, analyst forecasts, historical highs and lows, volatility, market capitalization, and financial reports. It also details recent earnings, revenue, net income, and confirms that the com", "url": "https://www.tradingview.com/symbols/BMV-OPK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T07:09:02", "published_display": "27 Jun 2026 07:09", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OPKO Health, Inc. \u2013 FWB:XCY", "summary": "This article provides a financial metric, the \"Price to earnings forward,\" for OPKO Health, Inc. (FWB:XCY) on the TradingView platform. It indicates that the company's financial data is available for review, though no specific values are presented in this snippet. The content pri", "url": "https://www.tradingview.com/symbols/FWB-XCY/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T03:10:45", "published_display": "27 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Opko Health, Inc. \u2013 NASDAQ:OPK", "summary": "This page from TradingView displays information related to the forward price-to-sales ratio for Opko Health, Inc. (NASDAQ: OPK). It indicates that the content is a financial data point for the company, accessible through the platform's market data and financial tools. The page it", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:09:49", "published_display": "27 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OPKO Health, Inc. \u2013 FWB:XCY", "summary": "The article focuses on the \"Price to book forward\" metric for OPKO Health, Inc. (FWB:XCY) listed on the Frankfurt Stock Exchange. It provides financial data context without presenting specific values in the clean content. The page also outlines various features and services offer", "url": "https://www.tradingview.com/symbols/FWB-XCY/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T19:09:49", "published_display": "26 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. Actuals & Estimates (NASDAQ:OPK)", "summary": "This article provides an overview of OPKO Health, Inc. (NASDAQ: OPK) stock, including its current price, market capitalization, historical highs and lows, and analyst forecasts. It also details the company's financial actuals and estimates for earnings and revenue, noting that OP", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-26T11:09:49", "published_display": "26 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XCY Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for OPKO Health, Inc. (XCY) stock based on analyst opinions. It includes details on the company's past performance, earnings, revenue, and other financial metrics. The article also addresses frequently asked questions about XCY, s", "url": "https://www.tradingview.com/symbols/FWB-XCY/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T20:40:45", "published_display": "25 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. Actuals & Estimates (TASE:OPK)", "summary": "This article provides an overview of OPKO Health, Inc. (TASE:OPK) stock, including its current price, performance, analyst forecasts, and financial data. It covers historical price movements, market capitalization, earnings reports, revenue, EBITDA, and employee count, alongside ", "url": "https://www.tradingview.com/symbols/TASE-OPK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T18:41:28", "published_display": "25 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPK Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and price target for Opko Health, Inc. (OPK) stock for 2027, based on analyst opinions. It includes current stock performance metrics, historical highs and lows, financial data like earnings and revenue forecasts, and other relevant compa", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T17:41:28", "published_display": "25 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus", "summary": "OPKO Health (OPK) is currently trading at $1.46, with analysts suggesting it could be 57% undervalued, pointing to a fair value of $3.40. This valuation is based on expected margin recovery after the sale of BioReference's oncology assets, aiming for profitability in its Diagnost", "url": "https://www.sahmcapital.com/news/content/opko-health-opk-stock-could-be-57-undervalued-as-margin-recovery-comes-into-focus-2026-06-24", "source_name": "Sahm", "published_at": "2026-06-25T09:40:44", "published_display": "25 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO HEALTH (OPK) director receives 80,000-share stock option grant", "summary": "OPKO Health director Uppaluri Subbarao V received a grant of stock options for 80,000 shares as part of standard director compensation. These options have an exercise price of $1.42 per share, become exercisable on June 18, 2027, and expire on June 17, 2036. The grant involved ca", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-3f90e421be16.html", "source_name": "Stock Titan", "published_at": "2026-06-23T13:39:53", "published_display": "23 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at OPKO (NASDAQ: OPK) receives grant of 60,000 stock options", "summary": "OPKO Health, Inc. director Richard C. Pfenniger Jr. was granted 60,000 stock options with an exercise price of $1.42 per share. These options become exercisable on June 18, 2027, and expire on June 17, 2036. This transaction was reported via an SEC Form 4 filing, indicating an aw", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-001a3124e021.html", "source_name": "Stock Titan", "published_at": "2026-06-23T01:40:45", "published_display": "23 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Opko Health For: 22 June By Investing.com", "summary": "The article \"Form 4 Opko Health For: 22 June\" by Investing.com reports on a Form 4 filing for Opko Health (OPK) dated June 22, 2026. This brief piece, which appears to be a standard financial markets update, mentions the company's stock performance (+2.74%) and reiterates the For", "url": "https://ng.investing.com/news/stock-market-news/form-4-opko-health-for-22-june-93CH-2568921", "source_name": "Investing.com Nigeria", "published_at": "2026-06-23T01:10:44", "published_display": "23 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health (OPK) director Roger Medel receives 30,000 stock options grant", "summary": "Opko Health (OPK) director Roger Medel has been granted 30,000 stock options, with an exercise price of $1.42 per share. These options will become exercisable on June 18, 2027, and have an expiration date of June 17, 2036. This transaction is considered a grant or award of deriva", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-568d0f3387b9.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:39:16", "published_display": "22 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health (OPK) director awarded 30,000 stock options at $1.42 strike", "summary": "OPKO Health director John A. Paganelli was granted 30,000 stock options at an exercise price of $1.42 per share as compensation. These options become exercisable on June 18, 2027, and will expire on June 17, 2036. Following this grant, Paganelli directly holds 30,000 options.", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-d2e3bc0c3561.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:39:16", "published_display": "22 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) director receives 30,000-share stock option award at $1.42", "summary": "OPKO Health director Prem A. Lachman was granted options for 30,000 shares of common stock at an exercise price of $1.42 per share on June 18, 2026. This award is compensation-related, not an open-market transaction, and brings his directly held option position to 30,000 shares w", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-9c429618ea58.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:39:16", "published_display": "22 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health Shareholders Back Board, Equity and Auditors", "summary": "Opko Health shareholders re-elected all eleven nominees to the Board of Directors, approved the 2026 Equity Incentive Plan, and endorsed executive compensation at their Annual Meeting. They also ratified Ernst & Young LLP as the independent auditor. Despite weak financial perform", "url": "https://www.theglobeandmail.com/investing/markets/stocks/OPK-Q/pressreleases/2561266/opko-health-shareholders-back-board-equity-and-auditors/", "source_name": "The Globe and Mail", "published_at": "2026-06-19T20:39:09", "published_display": "19 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should OPKO\u2019s New 15% Nicoya Stake and RAYALDEE Terms Require Action From OPKO Health (OPK) Investors?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing OPKO Health (OPK) Valuation After Expanded Nicoya RAYALDEE Partnership In Greater China", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSzF4eHlYWnY4Q1dUMGlkSXJXTlR5U1ZnOWxXdmhGMGMxbWtKVERrNTdkMVVnMDgtY3pJN1lJMU5lRTVFSHkwRzhSaks4UGpFd2puTkIzSFk2bDZTaW5PM0g2VFNKR0k2QmZuMG5XN1VIS25IbGw2eDZid1Y0WExYZlBXbjdKZlBGc0x2NFhDZjNEUlRCRnZIUElfbmFFSEN1dVM2bGlYMA?oc=5", "source_name": "Market source", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To OPKO Health (OPK) Boosting Its Nicoya Stake And RAYALDEE Milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPeXozTXZHSjBUMXNNLVo4NGFmenUxU1dPV09OUmpON0MyM0wwREpYUExId05DeGRYc3EtN3RUNEp0NllvTUdXMk44N3JSSnFZWk4zSkx5RWR0YkV3TTFvRFhPVDJqNExpV3RlTHdLXzRkbnJRUi1INnViVWNHNmg2czhsdWFLV3hrbnFORGVjbkp5cnRMR2c1M3BOX0FkSl9NSW91VA?oc=5", "source_name": "Market source", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/opko-health-opk-amends-partnership-215705278.html", "source_name": "Insider Monkey", "published_at": "2026-06-05T21:57:05+00:00", "published_display": "05 Jun 2026 21:57", "sentiment": "positive", "sentiment_pct": 58, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNV1RpWVhSTmwzMTV0U1JaZHQ5M2xtY3hMTUhOWWh4UVFHYU9VTTNDclNzblJmWUJGeE83MkRubmRfRGZnVVZBc0F5U1FXNG9hWjNJWjZqUDN0TmplYVRTLWxUMDFId1E0LXNpbkpxWjd3emh2R1NxSTNoOVZIanJ0R1hEalB6ZGZQNjFrcGRLbDAyOVU?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health stock (US68375N1037): earnings update keeps focus on pipeline and Rayaldee outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbUtYNDJlVjlXTXplVEt1NEpCWV92a3hiYmZKU3pUWnpVdTZqWm1NbXhuSE5WeG9sX0JiNldWWHN3QlVwak5vdEE3cDJQT1J2MkVzTWlvdUxkbzFnYVpsSC1VSTA1b05uM2ozQ1ExZzFPVHVOam50UzlteFFFRm1KRlBmMWdNVWZ6M3p2c3l0RTJ0ZnVNakVhci1yOXRHVF84UXBjTnJmWXZXVk9hTmhDR0p2c3FpM2RkX3VtOGZkMFVaUko4UklMVw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health\u2019s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/opko-health-modex-therapeutics-present-120000201.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Q1 Loss Of US$54.8 Million Tests Bullish Turnaround Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNSFQ4VUJCM1RqWXlFV0FuNHpNSDl4LTZqUHphOVpYZnVURV9BT3ZabWxUeFA5emxNcGliYU5UXzk3aVJqOTY2VWg5YTdmNlVpaHZ5dWNVWTAwQTAxRXFoV2JEN21wa0hkQzJxTmo4RFZXZGFNUG1IQU4tZGlpSjZOXzFFQmptQVJOaUg0NGIyT2tsNFRNaDV2ZUF0X2I0UzBMRUIxMDV3QThKOEZRMWVLeU1VV2QtM1JkYllLXy1qcnU1NENSeC15dWRxVldtNjVGWWhIVEthdXo5Y3U0LXdBcXY5MA?oc=5", "source_name": "OPKO Health, Inc.", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQRkdqaWFoa1RWUUZTcm9jbXllRmlsNVItcFVGWkR5bEl0dTY0dG5RR1E5OUJCbkFkSERRRzV5Z0ZYRno5ZWxaR2lKYmZJY19OT2xHaGhXd3JaVERlSzZUMmcxWlBzN1lGaDdEa2RXdzlyRE1vZmN6Ni1fWFV0LVFGRmJ3eXZjT1FQOEJQajlSTkdRam9ibnNGTHFYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The OPKO Health (OPK) Narrative Is Shifting After Mixed Results And A Lower Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQbEh3MXk0VFZSeXhUWjZrZ1VVRUhNZ2ZWR0xScC1vU0NpVmNKN09SQmUwdnV4UXZuSUJKWFB6VnRLNU1JWDVBOEExTUw0RWZ4ZFBpeEVONGNYcERzWEQtOE4yWEM4cTkwWmNBNFczM085ZUs1Y3pQTW5aVW9pOEV0cWZNZ3JQQlgzVEpVaE1USU9fU2JibFlxdVQzUnVhNk9u?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxONGpTUkxjdUJsREh1aV9wYmEyaldIM1NTRjB0UUthNDdPcl91WEtFQTFQeFpUUlNsMXZyZGRoakRrb25PTGtFeWYyNmdiSDhqUXB3bWFSNW82SWVDVG5LYlY1VmkyUGNWUnd4Rlg3OExDU1hsam9OTUJjbDdPSUY3NVVQWkJQX3VMelAwOVVVeHZXc0F5OWtKWFJfaw?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health: The Waiting Game Continues (NASDAQ:OPK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNdDZTdURCZTdTSUNHSHRMTFZLQmJ1SFpJdll3Y19iT2dqbXkxRlQ4M25JQXVFV1JLelp1YjFaUVA0MXRpckxaczFDZVZuZlVWbU13N0JzS2JOaHQ5cmNpOGZkdmxsbFlBeDFKcHZ3VmtXdXg0NmdJQ3loZ1JORV9JVnFKTVI1Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejFnVWQtd0hmdDB6TDNhY21LOUt5c1phVEpUSVM0OHhDZjJDUHB6VFB6eEVLNGVWbjZYQmpXNmYwT1lINk9fc1JDV3BYWWN4QWxlYnZOZ3pBZ0cxWm52WDNtUmpOU1BpRDhULV9scXpxVWU4T0JlTkF5NXhqcVpVYWl3VmRIZ3lkLVpaNkx2Tm8zYUZMYU16aHllVDZkR0VVSkxHSQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOaElkdHJTVl9SeTVGdXJFUDM5ejVJa0lXbzBtVjJ6Wl9JNWd5bDdNdVpWNU1MRlZqVS1oQUswTnJwRDZwWDF0OUEwN1RqSkNIUko4NWNEMWkwVDI5MmEwRllZWlMzRGFrMl9kN0pQWWRLWUNhc2NmXzVKYzdMWWZnci05YmlRSlZNbGRkcThzTHIweXNvSGduWEY4emJxdw?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health, Inc. (OPK) Stock Analysis: A Glimpse Into Potential 185% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOUDhBVXRsZGF5UU9qQ1dNX2ZkZl9HWlJkQjJaQWlzTXA0RFo4OXFieFlfalBPc0duT21oQ1YyWTNDWXVzNHpVeVpLNkxBV3hnOThUclVHcE1RcjFQWXNlOFpfbXVZeFRVU1ZoSlJpeXI2dV9XbFVzUk5sdkFfV0p5SktqQ0swcS1xdnd5QWY1Q2pFaWdodjk5RWlOUHZFWW0ydTlFdFBjRTIyajJBVUU0eERkNzBOTXNVVnN5SU9n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNemNMb2dZMVJlNUlZWDlSZHFiZlJfaEttNDN2U3V3OE9mdzBQVEl1Nk9ONW1CdmFLcFItNEN0U05JcDRKdnptU2YxVEV2aVVLRHJiR1hpN09iSkpNREw3MG05UlRfcGJNUjd1bjVYY0tCSUJoaWI2OGJWU2NyVmZpc0ZTdzlkLW11UVE?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Insider Ups Holding During Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQTzVPLWZjQkJpQlpHcHB4LS1iMGpEODRRS1VtRG9FS1RDbndnclk1b2dTaHZYN0t6R0l3N0w0Y2J2ZzhMN0EtYUt6ZEtqeHRZTmp0a2ttckJ2a0xHa29BTFFiMWZsMkZybndvejNmQUtJVXg3U1pLbG9iQnA1VTgxRGJlOA?oc=5", "source_name": "Market source", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNMWp6Z0hrdDE3cXRtMWFyVWdOSlEtZmhic3BxNHJSY0hmMjJMR2ZMOXVsaFRNazFtWVZZemZ1YTRmU2UwUW83ZjJoTnNhVTFENkVneFA1cHN1bDJTNmZOb1g0YnBucXhVNWlocFAxY1ZnZ0RfZzBLY3BMaGFGMTJVem1zNnFJYmpQNmt1S2daUmtjYXd2NHVJeWV3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health CEO Phillip Frost buys $737,747 in OPK stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQU3ZaUDJoV3dSN243T2FaVzFnWUFnZG9oUzZzaUt5YjdSSW96ckVoZm44Nzl6a21XNDQwS19xd0cxRWZYY3RDRTlXMEtmTGFuSmZfbzd5c3lWM1VIN1o3VVB1SHNtaU5BWEZ0WTlKZGZocU1iUEoyMWppLU92OFF6UXpmbkpJQWMwV3dfZUI1d0VETUVObDVOX0ZsSnRiVUxOSWlBOFdKbUpEeVhzQ09tT21jUXpfVjZfTjZv?oc=5", "source_name": "Investing.com", "published_at": "2025-11-18T08:00:00+00:00", "published_display": "18 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. to Announce Q3 2025 Financial Results and Business Update on October 29, 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNbXRmZWhZa0lDaFhVRUh4OEp0V3Y4MW5iZDcxVGRFZldhb1RxaWJsU0RSYUVfeEhzeWhWS1FfbWVoUkM0Tlk3b0IzZGREVWwyOFJudHpaZ0ZkdTlKdzBkZ2lvb1ZJcHBfTWdCd3AxWVo1TXdWdFJfUTU0VVRtelBQU3ktWTlFaGNQaU1jRXlXNGxIUEFTT2xzLTNNdWxPUWo1Vmx0ZXpVMkxfREEtbDlpa3M4aDFwcWxkcmpwTWJsSDVqQnZKYk9SSkc1WUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Retain OPKO Health Stock in Your Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE90amkyNDRGbFV2bnM4QndjNUEyRDl3S2Nkb3dqRnZhd2xQN2UybllubHVOYWxyZ0RMdTROWFJIWDQ2RXhQMXB2M1dDOW53REgyc2ZxVWpVaU9ZeHdlTEpFdzYyMG5uT04tblhTZGh2eEpCMHo3YXNrdlAteDFUaEU?oc=5", "source_name": "Market source", "published_at": "2025-06-13T07:00:00+00:00", "published_display": "13 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxNRWFvZTdyRUpkemNNSWRGOVpIQ2Zjel9qZExtdElJNHdHSE9vSEFoMW1IU0VRaVA3SWJRcDExeTZXeEYtUjZqOXlCN0hocThYNTQxT0owZGVRVVlQVm1DbVdPbVJyZ1h1aVV3cHJyUi0tZFg0WVM1VFJ0Ti13Y2cySVU3MXRqU05DSzhyWnMwcnFOQjBra2hScUtKdXAxRy1yYTdmU3RsTFdvX3VoOW4yRnNmMnRLMFlTODlZV0hfNG93TUo3MXpXN1dxMVFFaDJ6Ymw2aHA2VWUwTkZMVVd3Y2NrdWMzN2FXZ1JjYzJxVGhqS3h0V0szRWtnMXRBWGlTRW5OWXlXb3REbG1kTWFJbFVaaVZydmNCOHRwV0ZlYUNEUVpEdTEw?oc=5", "source_name": "OPKO Health, Inc.", "published_at": "2022-05-09T07:00:00+00:00", "published_display": "09 May 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "OPK5733212 Bond Profile \u2014 Key Metrics", "summary": "This article provides key metrics for the OPK5733212 bond issued by OPKO Health, Inc. The bond has a 3.75% coupon rate, was issued on January 9, 2024, and matures on January 15, 2029, with a face value of $1,000. OPKO Health, Inc. is described as a biopharmaceutical and diagnosti", "url": "https://www.tradingview.com/symbols/FINRA-OPK5733212/profile-overview/", "source_name": "TradingView", "published_at": "2026-07-15T02:11:29", "published_display": "15 Jul 2026 02:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zacks Research Has Weak Estimate for OPKO Health Q2 Earnings", "summary": "Zacks Research has reduced its Q2 2028 EPS estimate for OPKO Health (NASDAQ:OPK) to -$0.05 from -$0.04, reflecting a weaker outlook, though the full-year estimate remains at -$0.29 per share. This follows the company's recent quarterly results where EPS matched expectations at -$", "url": "https://www.marketbeat.com/instant-alerts/zacks-research-has-weak-estimate-for-opko-health-q2-earnings-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T05:39:46", "published_display": "13 Jul 2026 05:39", "sentiment": "negative", "sentiment_pct": 31, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in OPKO Health, Inc. Stocks", "summary": "This article lists various ETFs that invest in OPKO Health, Inc. stocks. It provides a detailed table including each ETF's market value, weight of OPKO in its holdings, issuer, management style, expense ratio, AUM, price, and 3-year NAV total return. The ETFs cover different inve", "url": "https://www.tradingview.com/symbols/LSE-0KCS/etfs/", "source_name": "TradingView", "published_at": "2026-07-10T20:10:34", "published_display": "10 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Piper Sandler 36th Annual Healthcare Conference Summary", "summary": "OPKO Health presented at the Piper Sandler 36th Annual Healthcare Conference, highlighting the growth of its Ngenla human growth hormone, with Pfizer projecting $500 million to $1 billion in near-term sales. The company also discussed its ModeX platform for multispecific antibodi", "url": "https://quartr.com/events/opko-health-opk-piper-sandler-36th-annual-healthcare-conference_3YClMjJo", "source_name": "Quartr", "published_at": "2026-07-05T20:10:34", "published_display": "05 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPK - Opko Health Inc Options", "summary": "This article provides a comprehensive overview of Opko Health Inc. (OPK) stock, including its latest closing price, key financial metrics, performance indicators, and ownership details. It details statistics such as market capitalization, income, sales, P/E ratio, EPS, insider an", "url": "https://finviz.com/stock?t=OPK&ta=1&p=d&ty=oc&b=2", "source_name": "Finviz", "published_at": "2026-07-03T17:40:13", "published_display": "03 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Inc focuses on diagnostics and pharmaceuticals as investors weigh long-term prospects", "summary": "OPKO Health Inc is building its business around both diagnostic services and specialty pharmaceutical products. The company aims to diversify its revenue streams and capitalize on growth opportunities in the healthcare sector. Investors are closely monitoring OPKO's strategy for ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/opko-health-inc-focuses-on-diagnostics-and-pharmaceuticals-as-investors/69680853", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T15:10:12", "published_display": "03 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 13D/A OPKO HEALTH For: 1 July By Investing.com", "summary": "This article announces that OPKO Health has filed a Form 13D/A for July 1st. It also includes general market data, popular news, and various financial statistics. The content itself provides no further details beyond the filing announcement.", "url": "https://uk.investing.com/news/stock-market-news/form-13da-opko-health-for-1-july-93CH-4753592", "source_name": "Investing.com UK", "published_at": "2026-07-03T07:10:12", "published_display": "03 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Ownership Update Draws Attention, Is The 55% Undervalued View Convincing?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Phillip Frost (NASDAQ: OPK) reports 34.1% beneficial stake in OPKO", "summary": "Phillip Frost has reported a significant 34.1% beneficial stake in OPKO Health (NASDAQ: OPK), totaling 255,429,406 shares. This ownership includes holdings through Gamma Trust, Frost Nevada Investments Trust, a philanthropic foundation, stock options, and restricted stock units. ", "url": "https://www.stocktitan.net/sec-filings/OPK/schedule-13d-a-opko-health-inc-amended-major-shareholder-report-62b64767f9ab.html", "source_name": "Stock Titan", "published_at": "2026-07-01T19:39:40", "published_display": "01 Jul 2026 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Opko Health, Inc. \u2013 NASDAQ:OPK", "summary": "This article presents financial data for Opko Health, Inc. (NASDAQ: OPK), specifically focusing on its enterprise value to EBITDA forward metric. The content was sourced from TradingView and includes general company and market information, but the specific financial value for the", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T06:10:45", "published_display": "29 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. Actuals & Estimates (BMV:OPK)", "summary": "This article provides an overview of OPKO Health, Inc. (BMV:OPK) stock, including current price, analyst forecasts, historical highs and lows, volatility, market capitalization, and financial reports. It also details recent earnings, revenue, net income, and confirms that the com", "url": "https://www.tradingview.com/symbols/BMV-OPK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T07:09:02", "published_display": "27 Jun 2026 07:09", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of OPKO Health, Inc. \u2013 FWB:XCY", "summary": "This article provides a financial metric, the \"Price to earnings forward,\" for OPKO Health, Inc. (FWB:XCY) on the TradingView platform. It indicates that the company's financial data is available for review, though no specific values are presented in this snippet. The content pri", "url": "https://www.tradingview.com/symbols/FWB-XCY/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T03:10:45", "published_display": "27 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Opko Health, Inc. \u2013 NASDAQ:OPK", "summary": "This page from TradingView displays information related to the forward price-to-sales ratio for Opko Health, Inc. (NASDAQ: OPK). It indicates that the content is a financial data point for the company, accessible through the platform's market data and financial tools. The page it", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:09:49", "published_display": "27 Jun 2026 00:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of OPKO Health, Inc. \u2013 FWB:XCY", "summary": "The article focuses on the \"Price to book forward\" metric for OPKO Health, Inc. (FWB:XCY) listed on the Frankfurt Stock Exchange. It provides financial data context without presenting specific values in the clean content. The page also outlines various features and services offer", "url": "https://www.tradingview.com/symbols/FWB-XCY/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T19:09:49", "published_display": "26 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. Actuals & Estimates (NASDAQ:OPK)", "summary": "This article provides an overview of OPKO Health, Inc. (NASDAQ: OPK) stock, including its current price, market capitalization, historical highs and lows, and analyst forecasts. It also details the company's financial actuals and estimates for earnings and revenue, noting that OP", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-06-26T11:09:49", "published_display": "26 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 63, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XCY Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for OPKO Health, Inc. (XCY) stock based on analyst opinions. It includes details on the company's past performance, earnings, revenue, and other financial metrics. The article also addresses frequently asked questions about XCY, s", "url": "https://www.tradingview.com/symbols/FWB-XCY/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T20:40:45", "published_display": "25 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. Actuals & Estimates (TASE:OPK)", "summary": "This article provides an overview of OPKO Health, Inc. (TASE:OPK) stock, including its current price, performance, analyst forecasts, and financial data. It covers historical price movements, market capitalization, earnings reports, revenue, EBITDA, and employee count, alongside ", "url": "https://www.tradingview.com/symbols/TASE-OPK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T18:41:28", "published_display": "25 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPK Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and price target for Opko Health, Inc. (OPK) stock for 2027, based on analyst opinions. It includes current stock performance metrics, historical highs and lows, financial data like earnings and revenue forecasts, and other relevant compa", "url": "https://www.tradingview.com/symbols/NASDAQ-OPK/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T17:41:28", "published_display": "25 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus", "summary": "OPKO Health (OPK) is currently trading at $1.46, with analysts suggesting it could be 57% undervalued, pointing to a fair value of $3.40. This valuation is based on expected margin recovery after the sale of BioReference's oncology assets, aiming for profitability in its Diagnost", "url": "https://www.sahmcapital.com/news/content/opko-health-opk-stock-could-be-57-undervalued-as-margin-recovery-comes-into-focus-2026-06-24", "source_name": "Sahm", "published_at": "2026-06-25T09:40:44", "published_display": "25 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO HEALTH (OPK) director receives 80,000-share stock option grant", "summary": "OPKO Health director Uppaluri Subbarao V received a grant of stock options for 80,000 shares as part of standard director compensation. These options have an exercise price of $1.42 per share, become exercisable on June 18, 2027, and expire on June 17, 2036. The grant involved ca", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-3f90e421be16.html", "source_name": "Stock Titan", "published_at": "2026-06-23T13:39:53", "published_display": "23 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at OPKO (NASDAQ: OPK) receives grant of 60,000 stock options", "summary": "OPKO Health, Inc. director Richard C. Pfenniger Jr. was granted 60,000 stock options with an exercise price of $1.42 per share. These options become exercisable on June 18, 2027, and expire on June 17, 2036. This transaction was reported via an SEC Form 4 filing, indicating an aw", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-001a3124e021.html", "source_name": "Stock Titan", "published_at": "2026-06-23T01:40:45", "published_display": "23 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Opko Health For: 22 June By Investing.com", "summary": "The article \"Form 4 Opko Health For: 22 June\" by Investing.com reports on a Form 4 filing for Opko Health (OPK) dated June 22, 2026. This brief piece, which appears to be a standard financial markets update, mentions the company's stock performance (+2.74%) and reiterates the For", "url": "https://ng.investing.com/news/stock-market-news/form-4-opko-health-for-22-june-93CH-2568921", "source_name": "Investing.com Nigeria", "published_at": "2026-06-23T01:10:44", "published_display": "23 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health (OPK) director Roger Medel receives 30,000 stock options grant", "summary": "Opko Health (OPK) director Roger Medel has been granted 30,000 stock options, with an exercise price of $1.42 per share. These options will become exercisable on June 18, 2027, and have an expiration date of June 17, 2036. This transaction is considered a grant or award of deriva", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-568d0f3387b9.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:39:16", "published_display": "22 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health (OPK) director awarded 30,000 stock options at $1.42 strike", "summary": "OPKO Health director John A. Paganelli was granted 30,000 stock options at an exercise price of $1.42 per share as compensation. These options become exercisable on June 18, 2027, and will expire on June 17, 2036. Following this grant, Paganelli directly holds 30,000 options.", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-d2e3bc0c3561.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:39:16", "published_display": "22 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) director receives 30,000-share stock option award at $1.42", "summary": "OPKO Health director Prem A. Lachman was granted options for 30,000 shares of common stock at an exercise price of $1.42 per share on June 18, 2026. This award is compensation-related, not an open-market transaction, and brings his directly held option position to 30,000 shares w", "url": "https://www.stocktitan.net/sec-filings/OPK/form-4-opko-health-inc-insider-trading-activity-9c429618ea58.html", "source_name": "Stock Titan", "published_at": "2026-06-22T21:39:16", "published_display": "22 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health Shareholders Back Board, Equity and Auditors", "summary": "Opko Health shareholders re-elected all eleven nominees to the Board of Directors, approved the 2026 Equity Incentive Plan, and endorsed executive compensation at their Annual Meeting. They also ratified Ernst & Young LLP as the independent auditor. Despite weak financial perform", "url": "https://www.theglobeandmail.com/investing/markets/stocks/OPK-Q/pressreleases/2561266/opko-health-shareholders-back-board-equity-and-auditors/", "source_name": "The Globe and Mail", "published_at": "2026-06-19T20:39:09", "published_display": "19 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should OPKO\u2019s New 15% Nicoya Stake and RAYALDEE Terms Require Action From OPKO Health (OPK) Investors?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing OPKO Health (OPK) Valuation After Expanded Nicoya RAYALDEE Partnership In Greater China", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNSzF4eHlYWnY4Q1dUMGlkSXJXTlR5U1ZnOWxXdmhGMGMxbWtKVERrNTdkMVVnMDgtY3pJN1lJMU5lRTVFSHkwRzhSaks4UGpFd2puTkIzSFk2bDZTaW5PM0g2VFNKR0k2QmZuMG5XN1VIS25IbGw2eDZid1Y0WExYZlBXbjdKZlBGc0x2NFhDZjNEUlRCRnZIUElfbmFFSEN1dVM2bGlYMA?oc=5", "source_name": "Market source", "published_at": "2026-06-07T07:00:00+00:00", "published_display": "07 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To OPKO Health (OPK) Boosting Its Nicoya Stake And RAYALDEE Milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPeXozTXZHSjBUMXNNLVo4NGFmenUxU1dPV09OUmpON0MyM0wwREpYUExId05DeGRYc3EtN3RUNEp0NllvTUdXMk44N3JSSnFZWk4zSkx5RWR0YkV3TTFvRFhPVDJqNExpV3RlTHdLXzRkbnJRUi1INnViVWNHNmg2czhsdWFLV3hrbnFORGVjbkp5cnRMR2c1M3BOX0FkSl9NSW91VA?oc=5", "source_name": "Market source", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/opko-health-opk-amends-partnership-215705278.html", "source_name": "Insider Monkey", "published_at": "2026-06-05T21:57:05+00:00", "published_display": "05 Jun 2026 21:57", "sentiment": "positive", "sentiment_pct": 58, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNV1RpWVhSTmwzMTV0U1JaZHQ5M2xtY3hMTUhOWWh4UVFHYU9VTTNDclNzblJmWUJGeE83MkRubmRfRGZnVVZBc0F5U1FXNG9hWjNJWjZqUDN0TmplYVRTLWxUMDFId1E0LXNpbkpxWjd3emh2R1NxSTNoOVZIanJ0R1hEalB6ZGZQNjFrcGRLbDAyOVU?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health stock (US68375N1037): earnings update keeps focus on pipeline and Rayaldee outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPbUtYNDJlVjlXTXplVEt1NEpCWV92a3hiYmZKU3pUWnpVdTZqWm1NbXhuSE5WeG9sX0JiNldWWHN3QlVwak5vdEE3cDJQT1J2MkVzTWlvdUxkbzFnYVpsSC1VSTA1b05uM2ozQ1ExZzFPVHVOam50UzlteFFFRm1KRlBmMWdNVWZ6M3p2c3l0RTJ0ZnVNakVhci1yOXRHVF84UXBjTnJmWXZXVk9hTmhDR0p2c3FpM2RkX3VtOGZkMFVaUko4UklMVw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health\u2019s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/opko-health-modex-therapeutics-present-120000201.html", "source_name": "GlobeNewswire", "published_at": "2026-05-12T12:00:00+00:00", "published_display": "12 May 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Q1 Loss Of US$54.8 Million Tests Bullish Turnaround Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNSFQ4VUJCM1RqWXlFV0FuNHpNSDl4LTZqUHphOVpYZnVURV9BT3ZabWxUeFA5emxNcGliYU5UXzk3aVJqOTY2VWg5YTdmNlVpaHZ5dWNVWTAwQTAxRXFoV2JEN21wa0hkQzJxTmo4RFZXZGFNUG1IQU4tZGlpSjZOXzFFQmptQVJOaUg0NGIyT2tsNFRNaDV2ZUF0X2I0UzBMRUIxMDV3QThKOEZRMWVLeU1VV2QtM1JkYllLXy1qcnU1NENSeC15dWRxVldtNjVGWWhIVEthdXo5Y3U0LXdBcXY5MA?oc=5", "source_name": "OPKO Health, Inc.", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQRkdqaWFoa1RWUUZTcm9jbXllRmlsNVItcFVGWkR5bEl0dTY0dG5RR1E5OUJCbkFkSERRRzV5Z0ZYRno5ZWxaR2lKYmZJY19OT2xHaGhXd3JaVERlSzZUMmcxWlBzN1lGaDdEa2RXdzlyRE1vZmN6Ni1fWFV0LVFGRmJ3eXZjT1FQOEJQajlSTkdRam9ibnNGTHFYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The OPKO Health (OPK) Narrative Is Shifting After Mixed Results And A Lower Price Target", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQbEh3MXk0VFZSeXhUWjZrZ1VVRUhNZ2ZWR0xScC1vU0NpVmNKN09SQmUwdnV4UXZuSUJKWFB6VnRLNU1JWDVBOEExTUw0RWZ4ZFBpeEVONGNYcERzWEQtOE4yWEM4cTkwWmNBNFczM085ZUs1Y3pQTW5aVW9pOEV0cWZNZ3JQQlgzVEpVaE1USU9fU2JibFlxdVQzUnVhNk9u?oc=5", "source_name": "Market source", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxONGpTUkxjdUJsREh1aV9wYmEyaldIM1NTRjB0UUthNDdPcl91WEtFQTFQeFpUUlNsMXZyZGRoakRrb25PTGtFeWYyNmdiSDhqUXB3bWFSNW82SWVDVG5LYlY1VmkyUGNWUnd4Rlg3OExDU1hsam9OTUJjbDdPSUY3NVVQWkJQX3VMelAwOVVVeHZXc0F5OWtKWFJfaw?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health: The Waiting Game Continues (NASDAQ:OPK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNdDZTdURCZTdTSUNHSHRMTFZLQmJ1SFpJdll3Y19iT2dqbXkxRlQ4M25JQXVFV1JLelp1YjFaUVA0MXRpckxaczFDZVZuZlVWbU13N0JzS2JOaHQ5cmNpOGZkdmxsbFlBeDFKcHZ3VmtXdXg0NmdJQ3loZ1JORV9JVnFKTVI1Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher (DHR) Projects 2026 Revenue Growth at TD Cowen 46th Annual Health Care Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPejFnVWQtd0hmdDB6TDNhY21LOUt5c1phVEpUSVM0OHhDZjJDUHB6VFB6eEVLNGVWbjZYQmpXNmYwT1lINk9fc1JDV3BYWWN4QWxlYnZOZ3pBZ0cxWm52WDNtUmpOU1BpRDhULV9scXpxVWU4T0JlTkF5NXhqcVpVYWl3VmRIZ3lkLVpaNkx2Tm8zYUZMYU16aHllVDZkR0VVSkxHSQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOaElkdHJTVl9SeTVGdXJFUDM5ejVJa0lXbzBtVjJ6Wl9JNWd5bDdNdVpWNU1MRlZqVS1oQUswTnJwRDZwWDF0OUEwN1RqSkNIUko4NWNEMWkwVDI5MmEwRllZWlMzRGFrMl9kN0pQWWRLWUNhc2NmXzVKYzdMWWZnci05YmlRSlZNbGRkcThzTHIweXNvSGduWEY4emJxdw?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health, Inc. (OPK) Stock Analysis: A Glimpse Into Potential 185% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOUDhBVXRsZGF5UU9qQ1dNX2ZkZl9HWlJkQjJaQWlzTXA0RFo4OXFieFlfalBPc0duT21oQ1YyWTNDWXVzNHpVeVpLNkxBV3hnOThUclVHcE1RcjFQWXNlOFpfbXVZeFRVU1ZoSlJpeXI2dV9XbFVzUk5sdkFfV0p5SktqQ0swcS1xdnd5QWY1Q2pFaWdodjk5RWlOUHZFWW0ydTlFdFBjRTIyajJBVUU0eERkNzBOTXNVVnN5SU9n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-03-17T07:00:00+00:00", "published_display": "17 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNemNMb2dZMVJlNUlZWDlSZHFiZlJfaEttNDN2U3V3OE9mdzBQVEl1Nk9ONW1CdmFLcFItNEN0U05JcDRKdnptU2YxVEV2aVVLRHJiR1hpN09iSkpNREw3MG05UlRfcGJNUjd1bjVYY0tCSUJoaWI2OGJWU2NyVmZpc0ZTdzlkLW11UVE?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Insider Ups Holding During Year", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQTzVPLWZjQkJpQlpHcHB4LS1iMGpEODRRS1VtRG9FS1RDbndnclk1b2dTaHZYN0t6R0l3N0w0Y2J2ZzhMN0EtYUt6ZEtqeHRZTmp0a2ttckJ2a0xHa29BTFFiMWZsMkZybndvejNmQUtJVXg3U1pLbG9iQnA1VTgxRGJlOA?oc=5", "source_name": "Market source", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health: Deeply Mispriced Ahead Of Major Catalysts (NASDAQ:OPK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNMWp6Z0hrdDE3cXRtMWFyVWdOSlEtZmhic3BxNHJSY0hmMjJMR2ZMOXVsaFRNazFtWVZZemZ1YTRmU2UwUW83ZjJoTnNhVTFENkVneFA1cHN1bDJTNmZOb1g0YnBucXhVNWlocFAxY1ZnZ0RfZzBLY3BMaGFGMTJVem1zNnFJYmpQNmt1S2daUmtjYXd2NHVJeWV3?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Opko Health CEO Phillip Frost buys $737,747 in OPK stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQU3ZaUDJoV3dSN243T2FaVzFnWUFnZG9oUzZzaUt5YjdSSW96ckVoZm44Nzl6a21XNDQwS19xd0cxRWZYY3RDRTlXMEtmTGFuSmZfbzd5c3lWM1VIN1o3VVB1SHNtaU5BWEZ0WTlKZGZocU1iUEoyMWppLU92OFF6UXpmbkpJQWMwV3dfZUI1d0VETUVObDVOX0ZsSnRiVUxOSWlBOFdKbUpEeVhzQ09tT21jUXpfVjZfTjZv?oc=5", "source_name": "Investing.com", "published_at": "2025-11-18T08:00:00+00:00", "published_display": "18 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-04T08:00:00+00:00", "published_display": "04 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health, Inc. to Announce Q3 2025 Financial Results and Business Update on October 29, 2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNbXRmZWhZa0lDaFhVRUh4OEp0V3Y4MW5iZDcxVGRFZldhb1RxaWJsU0RSYUVfeEhzeWhWS1FfbWVoUkM0Tlk3b0IzZGREVWwyOFJudHpaZ0ZkdTlKdzBkZ2lvb1ZJcHBfTWdCd3AxWVo1TXdWdFJfUTU0VVRtelBQU3ktWTlFaGNQaU1jRXlXNGxIUEFTT2xzLTNNdWxPUWo1Vmx0ZXpVMkxfREEtbDlpa3M4aDFwcWxkcmpwTWJsSDVqQnZKYk9SSkc1WUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-10-22T07:00:00+00:00", "published_display": "22 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why You Should Retain OPKO Health Stock in Your Portfolio", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE90amkyNDRGbFV2bnM4QndjNUEyRDl3S2Nkb3dqRnZhd2xQN2UybllubHVOYWxyZ0RMdTROWFJIWDQ2RXhQMXB2M1dDOW53REgyc2ZxVWpVaU9ZeHdlTEpFdzYyMG5uT04tblhTZGh2eEpCMHo3YXNrdlAteDFUaEU?oc=5", "source_name": "Market source", "published_at": "2025-06-13T07:00:00+00:00", "published_display": "13 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxNRWFvZTdyRUpkemNNSWRGOVpIQ2Zjel9qZExtdElJNHdHSE9vSEFoMW1IU0VRaVA3SWJRcDExeTZXeEYtUjZqOXlCN0hocThYNTQxT0owZGVRVVlQVm1DbVdPbVJyZ1h1aVV3cHJyUi0tZFg0WVM1VFJ0Ti13Y2cySVU3MXRqU05DSzhyWnMwcnFOQjBra2hScUtKdXAxRy1yYTdmU3RsTFdvX3VoOW4yRnNmMnRLMFlTODlZV0hfNG93TUo3MXpXN1dxMVFFaDJ6Ymw2aHA2VWUwTkZMVVd3Y2NrdWMzN2FXZ1JjYzJxVGhqS3h0V0szRWtnMXRBWGlTRW5OWXlXb3REbG1kTWFJbFVaaVZydmNCOHRwV0ZlYUNEUVpEdTEw?oc=5", "source_name": "OPKO Health, Inc.", "published_at": "2022-05-09T07:00:00+00:00", "published_display": "09 May 2022 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 99, "total_relevant": 52, "sentiment_summary": {"positive": 11, "negative": 4, "neutral": 37, "score": 51, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 15.55, "count": 27}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 18}, {"event": "deals", "label": "Deals and strategy", "weight": 2.75, "count": 5}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 1.35, "latest_week": "2026-07-10", "one_week_move": -11.2, "four_week_move": -4.9, "twelve_week_move": 8.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.18727, "market_dynamics_buy_signal": false, "relative_strength": -12.327831, "fair_value_gap": -3.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.3964, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-11.2% over one week, -4.9% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "TradingView", "count": 11}, {"label": "Stock Titan", "count": 6}, {"label": "simplywall.st", "count": 4}, {"label": "Ad-hoc-news.de", "count": 3}, {"label": "OPKO Health, Inc.", "count": 2}, {"label": "Seeking Alpha", "count": 2}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 27}, {"label": "Earnings", "count": 18}, {"label": "Deals and strategy", "count": 5}, {"label": "Macro sensitivity", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-11.2% over one week, -4.9% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "OPK5733212 Bond Profile \u2014 Key Metrics"}], "updated_at": "2026-07-16T02:16:17.496360+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}